Patient-specific comorbidities as prognostic variables for survival in myelofibrosis.
Sign Up to like & getrecommendations! Published in 2022 at "Blood advances"
DOI: 10.1182/bloodadvances.2021006318
Abstract: Treatment decisions in primary myelofibrosis (PMF) are guided by numerous prognostic systems. Patient specific comorbidities have influence on treatment related survival, and are considered in clinical contexts, but have not been routinely incorporated into current… read more here.
Keywords: specific comorbidities; prognostic variables; myelofibrosis; comorbidities prognostic ... See more keywords